Drugs Destroyed in Intensive Care and Their Annual Financial Burden

Havva Kubat; Elif Karabacak; Esra Aybal

doi:10.46332/aemj.1873050

Drugs Destroyed in Intensive Care and Their Annual Financial Burden

Abstract

Purpose: Unused medications can be considered a waste of resources. By reducing waste, the cost of healthcare services can be lowered without compromising the quality of patient care. This study aims to measure pharmaceutical waste in intensive care, draw attention to the economic dimension of waste, identify the causes of waste, and discuss possible preventive measures.

Materials and Methods: In a tertiary care unit with 15 beds at Adana City Hospital, the wasted drugs in one year were prospectively recorded.

Results: In a tertiary care unit where 1245 patients were treated in one year, the total cost of drugs annually was 226241.7 TL (approximately 5258 US dollars). Enteral nutrition solutions were the most wasted drug by volume, accounting for 33% of wasted drug volume. Levofloxacin caused the greatest cost loss among the wasted drugs, accounting for 18.4% of the total wasted drug cost. At least one drug was wasted in 30.4% (n=379/1245) of the patients. A total of 580 drug waste events were recorded. Disposal was detected in drugs with 26 different active ingredients. The most common reasons for drug waste were identified as: disposal of diluted solutions (59.7%, n=346), disposal of partially used drugs due to lack of small doses (31.7%, n=184), and disposal of contaminated drugs (8.6%, n=50).

Conclusion: Identifying the causes of waste is essential for initiating preventive measures. The extent and causes of drug waste should be determined in each clinic, and waste reduction strategies should be developed by optimizing drug preparation.

Keywords

Supporting Institution

None

Ethical Statement

Approval for this study was obtained from the Scientific Research Ethics Committee of Adana City Training and Research Hospital (11.09.2024 -Number:155).

Thanks

None

References

Badem AC,Başyiğit H. Üniversite hastanelerinde ilaç ve medikal malzeme maliyetlerinin değerlendirilmesi. Kocaeli Üniv Sos Bil Derg. 2017;34:62-84. https://izlik.org/JA79BR53YM
Biçer İ. OECD ülkelerinde ilaç harcamalarının belirleyicileri. TARR. 2025;10(4):920-935. doi: 10.30622/tarr.1800377
Barbariol F, Deana C, Lucchese F, et al. Evaluation of drug wastage in the operating rooms and ıntensive care units of a regional health service. Anesth Analg. 2021;132(5):1450-1456. doi:10.1213/ANE.0000000000005457
Fidan C, Ağırbaş İ. Yoğun bakım maliyetleri ve yoğun bakım maliyet çalışmalarının incelenmesi. Hacettepe Sağlık İdaresi Derg. 2020;23(3):485-504. https://izlik.org/JA74HD38UG
Majara P, Leballo G. Evaluation of wastage of commonly used anaesthetic agents in the operating theatres of a South African teaching hospital. S Afr Med J. 2025;115(2):29. doi:10.7196/SAMJ.2025.v115i2.2339
Karliner J, Slotterback S, Boyd R, Ashby B, Steele K, Wang J. Health care’s climate footprint: the health sector contribution and opportunities for action. Eur J Public Health. 2020;30(Supplement_5):ckaa165.843. doi:10.1093/eurpub/ckaa165.843
Sherman J, Thiel C, MacNeill A, et al. The green Print: advancement of environmental sustainability in healthcare. Resour, Conserv and Recycl. 2020;161:104882. doi:10.1016/j.resconrec.2020.104882
Sağlık Bakanlığı, https://akilciilac.titck.gov.tr/home/nedenakilcilackullanimi son erişim 25.05.2026

Merkez Bankası, https://www.turkiye.gov.tr/doviz-kurlari son erişim 27.11.2025
Tıbbi atıkların kontrolü yönetmeliği. https://www.mevzuat.gov.tr/mevzuat Mevzuat No=23273
Atcheson CLH, Spivack J, Williams R, Bryson EO. Preventable drug waste among anesthesia providers: opportunities for efficiency. J Clin Anesth. 2016;30:24-32. doi:10.1016/j.jclinane.2015.12.005
Tomson C. Reducing the carbon footprint of hospital-based care. Future Hosp J. 2015;2(1):57-62. doi:10.7861/futurehosp.2-1-57
Kurutkan MN, Usta E, Simsir I, Orhan F, Bagis M. Waste Management Approaches in Hospital Organizations and an Example of Practice. Balkan Mil Med Rev. 2014;17(1):10-15. DOI 10.5455/bmmr.159148
Doğanay M, Akçay K, Çil T, et al. KEPAN enteral beslenme rehberi. Clin Sci Nutr. 2023;5:1-29. doi:10.5152/ClinSciNutr.2023.23061
Aslan Y, Kanmaz Demir L. A General Evaluation of the Reasons for Medication Wastage: A University Hospital Example. SHYD. 2023;10(1):79-86. doi:10.54304/SHYD.2023.47113
Özdemir A, Esen ES, Esen M fevzi, Kaya BM. İlaç imhalarının değerlendirilmesi: Bir hastane örneği. Sag Aka Derg. 2024;11(2):286-292. doi:10.52880/sagakaderg.1434457
Hamilton TE. Office of Clinical Standards and Quality/Survey Certification Group Safe Use of Single Dose/Single Use Medications to Prevent Healthcare-associated Infections Ref: S&C: 12-35-ALL2012. https://www.cms.gov/medicare/provider-enrollment-and-certification/surveycertificationgeninfo/downloads/survey-and-cert-letter-12-35.pdf
Forshay CM, Hansen KN, Eckel SF. Using intravenous pump infusion data to optimize continuous infusion concentrations and reduce drug and fluid waste. Am J Health Syst Pharm. 2020;77(18):1497-1503. doi:10.1093/ajhp/zxaa199
Kahveci FŞ, Demirkan SK, Doğanay M, et al. KEPAN parenteral nütrisyon rehberi. Clin Sci Nutr. 2022;4:36-63. doi:10.5152/ClinSciNutr.2022.220124
AlSamanhodi H, Almeshary M, Amoh K, et al. Evaluation of the causes and cost impact of returned intravenous medications at a tertiary care hospital in Riyadh, Saudi Arabia. Trop J Pharm Res. 2017;16(1):231-237. doi:10.4314/tjpr.v16i1.31
Şimşir İ, Bağış M, Kurutkan MN, Oğuz B. Sağlık Hizmetlerinde İsraf Yönetimi. IV. Sağlıkta Kalite ve Performans Kongresi Sözel Bildiriler Kitabı. 2013;1:21-38.
SKS Hastane (Sürüm 6.1) 1. Baskı: Ankara, Haziran 2020.
Eckelman MJ, Huang K, Lagasse R, Senay E, Dubrow R, Sherman JD. Health Care Pollution And Public Health Damage In The United States: An Update. Health Aff (Millwood). 2020;39(12):2071-2079. doi:10.1377/hlthaff.2020.01247

Details

Primary Language

English

Subjects

Intensive Care

Journal Section

Research Article

Authors

Havva Kubat ^*
0000-0003-0958-9045
Türkiye

Elif Karabacak
0000-0003-2054-4542
Türkiye

Esra Aybal
0000-0002-3237-4838
Türkiye

Publication Date

August 31, 2026

Submission Date

February 21, 2026

Acceptance Date

June 25, 2026

Published in Issue

Year 2026 Volume: 10 Number: 2

DOI

https://doi.org/10.46332/aemj.1873050

IZ

https://izlik.org/JA59DZ35PT

Cite

RIS / Bibtex

APA

Kubat, H., Karabacak, E., & Aybal, E. (2026). Drugs Destroyed in Intensive Care and Their Annual Financial Burden. Ahi Evran Medical Journal, 10(2), 284-291. https://doi.org/10.46332/aemj.1873050

AMA

1.Kubat H, Karabacak E, Aybal E. Drugs Destroyed in Intensive Care and Their Annual Financial Burden. Ahi Evran Med J. 2026;10(2):284-291. doi:10.46332/aemj.1873050

Chicago

Kubat, Havva, Elif Karabacak, and Esra Aybal. 2026. “Drugs Destroyed in Intensive Care and Their Annual Financial Burden”. Ahi Evran Medical Journal 10 (2): 284-91. https://doi.org/10.46332/aemj.1873050.

EndNote

Kubat H, Karabacak E, Aybal E (August 1, 2026) Drugs Destroyed in Intensive Care and Their Annual Financial Burden. Ahi Evran Medical Journal 10 2 284–291.

IEEE

[1]H. Kubat, E. Karabacak, and E. Aybal, “Drugs Destroyed in Intensive Care and Their Annual Financial Burden”, Ahi Evran Med J, vol. 10, no. 2, pp. 284–291, Aug. 2026, doi: 10.46332/aemj.1873050.

ISNAD

Kubat, Havva - Karabacak, Elif - Aybal, Esra. “Drugs Destroyed in Intensive Care and Their Annual Financial Burden”. Ahi Evran Medical Journal 10/2 (August 1, 2026): 284-291. https://doi.org/10.46332/aemj.1873050.

JAMA

1.Kubat H, Karabacak E, Aybal E. Drugs Destroyed in Intensive Care and Their Annual Financial Burden. Ahi Evran Med J. 2026;10:284–291.

MLA

Kubat, Havva, et al. “Drugs Destroyed in Intensive Care and Their Annual Financial Burden”. Ahi Evran Medical Journal, vol. 10, no. 2, Aug. 2026, pp. 284-91, doi:10.46332/aemj.1873050.

Vancouver

1.Havva Kubat, Elif Karabacak, Esra Aybal. Drugs Destroyed in Intensive Care and Their Annual Financial Burden. Ahi Evran Med J. 2026 Aug. 1;10(2):284-91. doi:10.46332/aemj.1873050